Y10S 435/81
Packaged device or kit
Y10S435/81 (Packaged device or kit) appears on 2,992 US grants and 1,020 published applications in this corpus.
Search patents in Y10S- Granted patents
- 2,992
- Published applications
- 1,020
- Assignees
- 1,172
- Inventors
- 4,261
- Latest grant
- 20 Feb 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 9 | 0 |
| 1978 | 6 | 0 |
| 1979 | 0 | 0 |
| 1980 | 20 | 0 |
| 1981 | 40 | 0 |
| 1982 | 38 | 0 |
| 1983 | 30 | 0 |
| 1984 | 31 | 0 |
| 1985 | 38 | 0 |
| 1986 | 52 | 0 |
| 1987 | 79 | 0 |
| 1988 | 106 | 0 |
| 1989 | 125 | 0 |
| 1990 | 92 | 0 |
| 1991 | 74 | 0 |
| 1992 | 69 | 0 |
| 1993 | 65 | 0 |
| 1994 | 67 | 0 |
| 1995 | 80 | 0 |
| 1996 | 137 | 0 |
| 1997 | 164 | 0 |
| 1998 | 204 | 0 |
| 1999 | 159 | 0 |
| 2000 | 121 | 0 |
| 2001 | 133 | 32 |
| 2002 | 103 | 126 |
| 2003 | 125 | 133 |
| 2004 | 86 | 74 |
| 2005 | 72 | 86 |
| 2006 | 90 | 89 |
| 2007 | 69 | 101 |
| 2008 | 68 | 72 |
| 2009 | 93 | 71 |
| 2010 | 85 | 60 |
| 2011 | 71 | 40 |
| 2012 | 60 | 42 |
| 2013 | 28 | 26 |
| 2014 | 27 | 23 |
| 2015 | 25 | 16 |
| 2016 | 19 | 5 |
| 2017 | 13 | 13 |
| 2018 | 3 | 1 |
| 2019 | 7 | 4 |
| 2020 | 1 | 3 |
| 2021 | 1 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Integrated device for analyte testing, confirmation, and donor identity verification20 Feb 2024US 11,906,512 B2Zeus Diagnostics, LLC
- Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof8 Nov 2022US 11,492,411 B2Amgen Fremont Inc.
- Compositions comprising a P75 tumor necrosis factor receptor/Ig fusion protein31 Aug 2021US 11,104,714 B2Immunex Corporation
- Decubitus treatment system17 Nov 2020US 10,835,569 B2Aloe Bioscience, LLC
- Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof17 Dec 2019US 10,508,153 B2Amgen Fremont Inc.
- Antibody fc variants18 Jan 2024US 2024/0018259 A1Roche Glycart AG
- Compositions comprising a p75 tumor necrosis factor receptor/ig fusion protein27 Jan 2022US 2022/0025016 A1Immunex Corporation
- Antibody fc variants13 May 2021US 2021/0139603 A1Roche Glycart AG
- Use of an antibody specific for BDCA 2 for ligation and removal of dendritic cells in the treatment systemic lupus erythematosis10 Sep 2020US 2020/0283499 A1Miltenyi Biotec GmbH
- B7-related nucleic acids and polypeptides useful for immunomodulation12 Mar 2020US 2020/0079835 A1
Most cited
By later US patents
- Mesoscale polynucleotide amplification devices1,091US 5,587,128 AThe Trustees of the University of Pennsylvania · 1996
- Medical droplet whole blood and like monitoring1,055US 4,995,402 AThorne, Smith, Astill Technologies, Inc. · 1991
- Mesoscale polynucleotide amplification device and method1,042US 5,498,392 AThe Trustees of the University of Pennsylvania · 1996
- Concentrating zone method in heterogeneous immunoassays1,023US 4,366,241 ASyva Company · 1982
- Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems1,006US 5,637,469 AThe Trustees of the University of Pennsylvania · 1997